Edwards Lifesciences to Present at the Canaccord Genuity Growth Conference

Edwards Lifesciences to Present at the Canaccord Genuity Growth Conference 
IRVINE, CA -- (Marketwired) -- 08/12/13 --  Edwards Lifesciences
Corporation (NYSE: EW), the global leader in the science of heart
valves and hemodynamic monitoring, is scheduled to present at the
Canaccord Genuity Growth Conference 2013 on Wednesday, August 14,
2013. Thomas M. Abate, Edwards' corporate vice president and chief
financial officer, is scheduled to speak to attendees at the
InterContinental Boston at 2:30 p.m. EDT. 
A live webcast will be available to all interested parties on the
Edwards Lifesciences investor relations website at
http://ir.edwards.com. Following the presentation, an archived
version of the webcast will be available on the Edwards investor
relations website in the News and Events section and via the Edwards
Lifesciences Investor Relations App for mobile devices. 
About Edwards Lifesciences
 Edwards Lifesciences is the global leader
in the science of heart valves and hemodynamic monitoring. Driven by
a passion to help patients, the company partners with clinicians to
develop innovative technologies in the areas of structural heart
disease and critical care monitoring that enable them to save and
enhance lives. Additional company information can be found at
www.edwards.com.  
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks
of Edwards Lifesciences Corporation.  
Media Contact: 
Sarah Huoh
949-250-5070 
Investor Contact: 
David K. Erickson
949-250-6826 
Edwards Lifesciences Corporation
One Edwards Way
Irvine, CA USA 92614 
Phone: 949.250.2500 
Fax: 949.250.2525
www.edwards.com 
 
 
Press spacebar to pause and continue. Press esc to stop.